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Porcine parvovirus (PPV) is one of many pathogens responsible for reproductive failure in pregnant sows. Several
studies have reported the appearance of new PPV strains that differ from previous isolates both genetically and
antigenically. Thus, the protective effects of commercially inactivated vaccines could not be complete. In South
America, the information about PPV is limited. Thus, the aim of the present study was to detect and characterize
the PPV strains present in 131 mummies or stillbirths from normal deliveries in sows from a commercial swine
farm of Argentina that uses the commercial vaccine. PCR results showed that 17/131 were positive to PPV. Ten of
these viruses were isolated and sequenced. All viruses were related to the PPV1 sequence (NADL-2), maintaining
the amino acid differences in positions 436 (S–P) and 565 (R–K). This study is the first to report the isolation of
PPV in Argentina and the results suggest that PPV can cross the placenta even in vaccinated sows, thus affecting
some of the fetuses and being able to cause fetal death in sows without reproductive failure. The results also
suggest that vaccination only reduces clinical signs and reproductive disorders and may thus not be a perfect tool
to manage PPV infection. This study provides information that needs to be studied in depth to improve strategies
to prevent and control PPV infection in swine farms.1. Introduction
Porcine parvovirus (PPV) is one of many pathogens responsible for
reproductive failure in pregnant sows. Epidemiological studies and
diagnostic surveys have demonstrated that PPV is the main causative
agent responsible for embryonic and fetal death in swine, causing
mummification, stillbirths and delayed return to estrus (Mengeling,
2006). Parvoviruses are taxonomically classifiable into two subfamilies
based on their host range: the Parvovirinae, which infect vertebrates, and
the Densovirinae, which infect mainly insects and other arthropods (Ni
et al., 2014). Viruses that infect swine are classified into Protoparvovirus,
Bocaparvovirus, Copiparvovirus and Tetraparvovirus and the most rep-
resentatives are: porcine parvovirus 1 (PPV1), PPV2, PPV3, PPV4, PPV5,
PPV6, porcine bocavirus 1 (PBoV1), PBoV2, PBoV3A, PBoV3B, PBoV3C,
PBoV3D and PBoV3E (Cotmore et al., 2019; Gava et al., 2015).
A typical parvovirus is non-enveloped, possesses a small and single-.com.ar (M.G. Echeverría).
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is an open access article under tstranded DNA genome of 4–6.3 kb in length, and generally contains
two open reading frames (ORFs): ORF1, encoding for a non-structural
protein (NS1), and ORF2, encoding at least 2 capsid proteins -VP1 and
VP2- (Allander et al., 2005). An additional ORF, named ORF3, which has
been identified in some parvoviruses, encodes the accessory protein NP1,
a non-structural protein found only in bocaviruses and PPV4 (Cheng
et al., 2010; Cheung et al., 2010).
The capsid protein VP2 harbors major antigenic domains of PPV,
which can induce PPV neutralizing antibodies. Thus, VP2 is the main
target protein to neutralizing antibodies and plays a key role in PPV
diagnosis and immune prophylaxis (Xu and Li, 2007; Kong et al., 2014).
Despite the high level of conservation in the parvovirus sequence, PPV
strains can be distinguished by their different pathogenicity. Some res-
idue substitutions of the VP2 gene between the attenuated strain NADL-2
and the virulent Kresse strain (D378 -G, H383 –Q and S436 –P) have been
found to play a crucial role in the function and properties of VP2. TheseNovember 2019
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the Kresse strain, and all are located on the surface of the capsid. Besides,
five differences have been found to be consistently present in the se-
quences of the Kresse strain and field isolates (I215 -T, D378 -G, H383 -Q,
S436 –P and R565 -K) (Bergeron et al., 1996; Simpson et al., 2002; Shangjin
et al., 2009).
Several studies have reported the appearance of new PPV strains that
differ antigenically from previous isolates (Soares et al., 2003; Zimmer-
mann et al., 2006). Furthermore, the protective effects of commercially
available vaccines have shown lower neutralization activity against some
of these new strains (Zeeuw et al., 2007; Jozwik et al., 2009). Vaccines
against PPV can be attenuated vaccines, inactivated vaccines, subunit
vaccines and DNA vaccines. Attenuated vaccines, which have been used
in some countries for several years, are expensive, cause side effects, and
may revert to a pathogenic strain. However, they are likely to be more
reactogenic and immunogenic than inactivated, subunit and DNA vac-
cines (Lima et al., 2004; Chen et al., 2010). Subunit vaccines elicit only
moderate levels of protection and inactivated vaccines show deficiencies
of specific cellular immune efficacy and failure to increase immunoge-
nicity of weak antigens. However, despite these latter limitations of
inactivated vaccines, they are the most common type of PPV vaccines
used (Wang et al., 2012). In Argentina, only commercial inactivated PPV
vaccines are available and are thus widely used to control reproductive
failure due to PPV.
In South America, information about the subfamily Parvovirinae is
limited. Soares et al. (2003) reported an analysis of the diversity of PPV
strains in Brazil, by using the partial sequencing of the VP2 encoding
gene. In Argentina, only an analysis on the diversity and characterization
of canine parvovirus has been reported (Gallo Calderon et al., 2012). It is
expected that PPV is present in most of the pig intensive commercial
farms as an endemic disease as it occurs in other parts of the world;
however, no report about this disease has yet been published in our
country.
Based on the above, the objective of this study was to detect and
characterize the strains of PPV present in mummies and stillbirth piglets
collected from a subclinically infected farm in Argentina.
2. Material and methods
2.1. Sample collection and DNA extraction
A 2500-sow multi-site farrow-to-finish farm located in Santa Fe
province, Argentina, was selected for the study. In this farm, the vacci-
nation program against reproductive diseases includes commercial PPV
(NADL-2) and leptospira inactivated vaccine during acclimation
(170–190 days old) and 14 days before every mating. The farm is free of
brucellosis, Aujeszky disease virus, porcine reproductive and respiratory
stress syndrome virus and classical swine fever virus. The age of first
mating is 230–240 days old.
Stillbirths and mummies from randomly selected normal deliveries
(<2% of stillbirths and >11 born alive) were collected. From September
to December 2016, a total of 131 mummies and stillborn (that represent
1.5% of the total of mummies and stillborn of the time frame studied)
belonging to 74 sows (with more than one parity) were analyzed. The
complete fetuses were placed in individual sterile bags, preserved at 4 C,
and taken to our Laboratory (Laboratorio de Virología, Facultad de
Ciencias Veterinarias, Universidad Nacional de La Plata, La Plata,
Argentina). Samples were preserved at -20 C until analysis. At the lab-
oratory, the crown-rump length of each fetus was measured and the
following formula: days of gestation ¼ length (in mm) x 3 þ 21 was
applied to estimate the fetal death age (Kirkwood et al., 2012). There-
after, fetuses were classified into mummies, Type I and Type II stillbirths,
according to Christianson (1992). Samples of tonsil, lung, liver, heart and
kidney were individually collected from each fetus and immediately
pooled and processed for routine virus isolation and PCR detection. Total
DNA was extracted from sample homogenates by using the Wizard2
Genomic DNA Purification Kit (Promega-USA) according to the manu-
facturer's instructions.
2.2. PPV detection and sequence analysis
PCR detection was used to test all samples to amplify the highly
conserved NS1 partial gene by using the PPVm Fw 50-
CTTGGAGCCGTGGAGCGAGC-30 and PPVm Rv 50- TGCA-
CAGTTTTCACCAAAGCAGGC-30 primers. The reaction was carried out in
a final volume of 25 μl mixture containing 5X PCR buffer, 10 pmol of
dNTPs, 10 pmol of each primer, 1 Units of Go Taq DNA polymerase
(Promega) and 7% of DMSO. The reaction conditions were as follows:
pre-denaturation at 94 C for 5 min, followed by 35 cycles of 95 C for 45
s, 60 C for 45 s, 72 C for 45 s, and a final elongation step at 72 C for 7
min. PCR products were electrophoresed in 2% agarose gels in standard
TBE buffer and stained with ethidium bromide. The analytical sensitivity
of the PCR was determined using dilutions in base 10 of DNA positive
control.
For sequence analysis, the VP2 gene was amplified as described by
Soares et al. (2003). The PCR products were purified according to the
manufacturer's protocols by using the Wizard SV Gel and PCR Clean-Up
System (Promega, Madison, WI, USA). Sequencing reactions were per-
formed in both directions with the same primers for amplification by
PCR, using an automated sequencer (3130xl/3500xl Genetic Analyzer,
Applied Biosystems, USA), at the Unidad Genomica of the National
Institute of Agricultural Technology (INTA Castelar), Argentina.
The sequences were edited using BioEdit software version 7.2.1.
Homology analyses were performed with the BLASTN program (National
Center for Biotechnology Information [http://www.ncbi.nlm.nih
.gov/BLAST/]). For PPV analysis, the partial sequences of VP2 were
aligned in the MEGA program version 7.0, using the ClustalW algorithm.
The phylogenetic dataset included 10 sequences obtained in this study
and 53 sequences from GenBank, including PPV1, PPV2, PPV3 and PPV4
types and several PPV geographically related strains (Table 1). The
phylogenetic trees were constructed using MEGA program. The evolu-
tionary history was inferred by using the Maximum Likelihood (ML)
method based on the Kimura 2-parameter model. Initial tree(s) for the
heuristic search were obtained automatically by applying the Neighbor-
Joining and BioNJ algorithms to a matrix of pairwise distances estimated
using the Maximum Composite Likelihood (MCL) approach, and then
selecting the topology with superior log likelihood value. The nucleotide
sequences obtained in this study were submitted to GenBank and
accession numbers are shown in Table 1.
2.3. PPV isolation
The methodology used was adapted according to Trindade et al.
(2011) and Soares et al. (1999). Virus isolation was attempted with
cloned porcine kidney (CPK) cells maintained in minimal essential me-
dium (MEM) supplemented with L-glutamine and 10% fetal bovine
serum. Infection of cells was performed simultaneously with cell
disruption using trypsin. Confluent monolayer cultures of CPK cells
grown in six-well plates were inoculated with serial decimal dilutions
(101 to 103) of a positive PCR tissue pool in MEM. The plates were
incubated at 37 C for 60 min in an atmosphere of 5% CO2. After
removing the inoculum, trypsin solution was added and incubated for 5
min. The cells were collected and transferred into T25 cell culture flasks.
The cell culture was reincubated at 37 C and examined daily for cyto-
pathic effects until the fifth day. Then, two more repetitions using the
samemethod were made for each sample and finally presence of PPVwas
evaluated by PCR and then, positive supernatants were titrated by the
hemagglutination test. Guinea pig bloods were collected into Alsever's
solution and stored at 4 C. Erythrocytes were washed 3 times and final
suspensions made up to 0.6% using phosphate buffered saline (PBS) at
pH 7.2 was used as diluent throughout. Positive virus suspensions were
stored at -70 C.
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8a JN400517.1 Germany Streck et al., (2013)
7a JN400516.1 Germany Streck et al., (2013)
693a JN400519 Austria Streck et al., (2013)
14a JN400518.1 Germany Streck et al., (2013)
15425 JN400520.1 Switzerland Streck et al., (2013)
WB631 JQ249917.1 Romania Cadar et al., (2012)
WB748 JQ249922 Romania Cadar et al., (2012)
WB639 JQ249918 Romania Cadar et al., (2012)
WB613 JQ249916 Romania Cadar et al., (2012)
WB804 JQ249926 Romania Cadar et al., (2012)
WB716 JQ249921.1 Romania Cadar et al., (2012)
Tornau AY684869 Germany Zimmermann et al.,
(2006)
Challenge AY684866 UK Zimmermann et al.,
(2006)
106b AY684870.1 Germany Zimmermann et al.,
(2006)
27a AY684871.1 Germany Zimmermann et al.,
(2006)
21a AY684868.1 Germany Zimmermann et al.,
(2006)
143a AY684867.1 Germany Zimmermann et al.,
(2006)
4e GQ884047.1 USA Unpublished




27–00 AY145477.1 Brazil Soares et al., (2003)
142–95 AY145474.1 Brazil Soares et al., (2003)
32–96 AY145472.1 Brazil Soares et al., (2003)
83–95 AY145473.1 Brazil Soares et al., (2003)
13–97 AY145492.1 Brazil Soares et al., (2003)
05–95 AY145488.1 Brazil Soares et al., (2003)
91–94 AY145487.1 Brazil Soares et al., (2003)
75–95 AY145486.1 Brazil Soares et al., (2003)
124–95 AY145481.1 Brazil Soares et al., (2003)
12–97 AY145482.1 Brazil Soares et al., (2003)
13–97 AY145492.1 Brazil Soares et al., (2003)
155–95 AY145493.1 Brazil Soares et al., (2003)
110–95 AY145490.1 Brazil Soares et al., (2003)
103–95 AY145480.1 Brazil Soares et al., (2003)
Campinas AY145500.1 Brazil Soares et al., (2003)
49–96 AY145498.1 Brazil Soares et al., (2003)
40–96 AY145497.1 Brazil Soares et al., (2003)
111–00 AY145499.1 Brazil Soares et al., (2003)
71–00 AY145479.1 Brazil Soares et al., (2003)
58–00 AY145478.1 Brazil Soares et al., (2003)
Itabera/SP AY145475.1 Brazil Soares et al., (2003)
39–96 AY145476.1 Brazil Soares et al., (2003)
Kresse U44978.1 USA Bergeron et al., (1996)
SR1 DQ675456 China Unpublished
POVG D00623 Spain Ranz et al., 1989
NADL-2 L23427.1 USA Bergeron et al., (1996)
318 AY583318 China Qing et al., 2006
H2 MN182471 Argentina This study
3363 MN182472 Argentina This study
2220–1 MN182473 Argentina This study
CC7 MH091023 Argentina This study
5534 MN182474 Argentina This study
2761 MN182475 Argentina This study
CC9/15 MN182476 Argentina This study
8504 1 MN182477 Argentina This study
5645 MN182478 Argentina This study
5551 MN182479 Argentina This study
JS0910-5400 GU978968.1 China Huang et al., 2010
JS0910-5644 GU978967.1 China Huang et al., 2010
F8–1994B FJ982250.1 Canada Szelei et al., 2010
F3 JQ860240.1 Romania Unpublished
F7 JQ860238.1 Romania Unpublished
CPV-N M19296.1 - Reed et al., 1988
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3. Results
3.1. Samples and PCR
A total of 131 fetuses belonging to 74 sows (with more than one
parity) were analyzed. Thirty-two percent (42/131) of the fetuses were
classified as mummies, 38.17% (50/131) as type I stillbirths and 29.77%
as a type II stillbirths (39/131). The mean age of the fetuses was 92.1
days old (range¼ 48–116). PCR amplification products were observed in
17 out of the 131 fetuses analyzed. The sensitivity of PCR for PPV was
determined in 4  106 ng/μl.
3.2. Phylogenetic analysis
Phylogenetic analysis demonstrated that all Argentinean strains
showed no differences between them and had high similarity to the PPV1
sequences. The phylogram obtained by ML analysis of the partial VP2
gene (494bp) showed the grouping of the PPV1, PPV2, PPV3 and PPV4
sequences (Fig. 1a). In accordance with previous reports by Cadar et al.
(2012), the following clusters were observed within the PPV1 strains:
cluster A, containing two highly virulent strains (Tornau AY684870.1
and JN400520.1) and one wild boar strain (WB-716); cluster B, including
several highly virulent strains from Germany, one domestic pig strain
from Austria, and one wild boar strain from Romania (WB-631); cluster
C, grouping domestic pig strains from the USA, Germany and Europe and
one wild boar strain from Romania; cluster D, grouping only two wild
boar strains (WB-613 and WB-639); cluster E, grouping the highly viru-
lent Kresse strain together with the challenge UK strain separately from a
wild boar strain (WB-804) and another group of sequences represented
by Brazilian domestic pig strains; cluster F, including a vaccine strain
(I18745.1) and other strains from Spain and China; cluster G, represented
by one Brazilian strain, one Chinese strain and the NADL-2 strain and all
the Argentinean strains obtained in this study; and cluster H, including
only Brazilian domestic pig strains. The PPV2 sequences (JQ860238.1
and JQ860240.1), the PPV3 sequence named F8–1994B, and the PPV4
strains (GU978968.1 and GU978967.1) grouped separately. A new
phylogram was obtained when including the Brazilian sequences and the
VP2 sequence of canine parvovirus (M19296.1) as outgroup. The
phylogenetic tree showed two defined groups of sequences named
Groups A and B, with similar distributions, as described by Soares et al.
(2003) (Fig. 1b). Group A included three subgroups: subgroup a,
including the Argentinean strains forming a separate group, NADL-2 and
I18745.1 vaccine strains, and three Brazilian strains associated with
mummification as clinical presentation (sequences represented as );
subgroup b, represented by the highly virulent Kresse strain together
with Brazilian strains, forming a group Kresse as described by Soares
et al. (2003), and two other Brazilian strains named 39–96 and Itaber-
a/SP in this study (sequences represented as ); and subgroup c (se-
quences represented as ), formed by virulent German strains
represented as Cluster B in Fig. 1a. In contrast to that described by Soares
et al., when including the Argentinean strains and other Brazilian strains,
some Brazilian strains (103–95, 05–95, 49–96 and 111–00) clustered
within group B and not within group A.
The phylogenetic tree from the amino acid sequence analysis main-
tained the same distribution of groups, differing only in the branch po-
sitions (data not shown). The analysis of differences between the NADL-2
and Kresse strains described by Bergeron et al. (1996) and Simpson et al.
(2002) allowed observing that all Argentinean strains the as NADL-2
strain maintained the amino acid differences in the amino acid posi-
tions 436 (S–P) and 565 (R–K).
3.3. PPV isolation
Virus isolation was attempted with CPK cells. Only one strain (CC7)
showed evident cytopathic effect. Besides, nine other viruses were
a b
Fig. 1. (a) Phylogenetic tree constructed by the Maximum Likelihood (ML) method based on the Kimura 2-parameter model based on partial DNA sequence of the VP2
gene. The tree shows the grouping of the PPV1, PPV2, PPV3 and PPV4 sequences. (b) Phylogenetic tree constructed by the Maximum Likelihood (ML) method based
on the Kimura 2-parameter model based on partial DNA sequence of the VP2 gene. This tree included 22 Brazilian sequences and the VP2 sequence of canine
parvovirus as outgroup. The phylogenetic tree shows two defined groups, A and B. Group A included three subgroups: subgroups a (sequences represented as );
subgroup b (sequences represented as ); and subgroup c (sequences represented as ). The Argentinean strains are marked with a circular line.
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as PPV by PCR and the hemagglutination test with titer of hemaggluti-
nation between 1:64 and 1:256.
4. Discussion
PPV is found in almost all pig-breeding countries and PPV1 is
considered endemic in swine herds worldwide. The main clinical sign of
PPV infection in non-immune sows is reproductive failure, characterized
by embryonic and fetal infection and death, usually without any clinical
signs in the dam (Mengeling et al., 1979). Since 800 parvovirus vacci-
nation is widespread in Argentina swine farms and serological evidence
of PPV infection were frequently observed. However, this is the first
report of PPV isolation and characterization. In recent years there are
numerous studies that showed genetic variation of PPV. Moreover, a
constant increase in mummies and stillborn are observed in several parts
of the world and also in Argentina. In this context it is imperative to study
PPV isolates to identify risk of vaccine failure associate to evolution of
PPV and the field efficacy of currently used vaccines. This study explored
the molecular characteristics of PPV strains in Argentina and of the
presence of PPV from fetuses and stillbirths delivered by sows without
reproductive failure in Argentina. All the samples analyzed in this study
were from fetal tissues of normal deliveries of vaccinated sows. The
detection of PPV in fetal tissues (17/131) suggests that PPV can cross the4
placenta in vaccinated sows, thus affecting some of the fetuses and
causing fetal death. This result is in agreement with previous experi-
mental studies showing that an inactivated whole-virus vaccine did not
protect against PPV infection (Jozwik et al., 2009; Foerster et al., 2016).
Differences in PCR-positive samples from fetal tissues between these
previous studies an our present study could be associated with the type of
samples analyzed; Jozwik et al. (2009) and Foerster et al. (2016)
analyzed only lung and kidney samples, whereas we studied tonsil, heart
and liver samples, according to other studies (Streck et al., 2013). In this
study, the detection of PPV in mummies and stillbirths collected from a
subclinically infected farm which uses the PPV inactivated vaccine sug-
gests, as expressed by other authors, that vaccinationmay not be a perfect
tool to manage PPV infection and that it only reduces clinical signs and
reproductive disorders (Jozwik et al., 2009; Foerster et al., 2016). It is
thus necessary to continue exploring the complete genome of PPV iso-
lates and perform new analyses that can demonstrate this hypothesis.
The biological significance of the sequence variation seen among the
isolates and vaccine strains is not clear yet (Zimmerman et al., 2006), and
the origin and role of the PPV vaccine strains associated with mummi-
fication are unknown. The vaccines against PPV currently available are
based on inactivated virus preparations of PPV1 strains isolated some 30
years ago. Experimental infection was demonstrated by the high mor-
tality among the fetuses of sows infected with the PPV-27a strain
compared with sows infected with other strains as well as with NADL-2
M.S. Serena et al. Heliyon 5 (2019) e02874(Zeeuw et al., 2007; Jozwik et al., 2009; Foerster et al., 2016).
Since field strains of PPV are difficult to be propagated in conven-
tional cell lines, molecular studies of DNA have been carried out directly
on clinical material. In the present study, we were able to isolate 10/17
PPV PCR-positive samples. Then, we analyzed the partial VP2 gene from
the 10 PPV strains isolated and other published sequences (Table 1). The
phylogram obtained of the partial VP2 gene showed the grouping of the
PPV1, PPV2, PPV3 and PPV4 sequences (Fig. 1a). Cadar et al. (2013)
described that comparative phylogeny of PPVs has placed PPV2 phylo-
genetically closer to PPV1, and PPV3 and PPV4 more distantly. In our
analysis, the two sequences considered as PPV2 were topologically more
distant from PPV1 sequences, probably due to the few sequences
included. As shown by Cadar et al. (2013), PPV3 and PPV4 sequences
grouped separately and different clusters were observed within PPV1
strains. The Argentinean strains grouped with NADL-2 vaccine strains
together with the 27-00 Brazilian strain in the same cluster, as previously
reported also by Soares et al. (2003), and they gave origin to group G.
Cotmore et al. (2014) described that the genomic organization of PPV6 is
similar to that of PPV5 but not to that of other PPV types, which contain
an ORF3 in the middle of the viral genome. Phylogenetic analysis
demonstrated that PPV6 and PPV5 form a distinct branch that is genet-
ically different from viruses of previously defined genera in the subfamily
Parvovirinae, and might be classified into the novel genus Copiparvovi-
rus. For this reason, in our study, we did not include the PPV5 and PPV6
sequences. Rooting the ML tree based on nucleotide sequences using the
reference VP2 sequence of canine parvovirus as outgroup, as seen in
Fig. 1b, allowed the identification of two groups named Groups A and B,
whose distribution was similar to that described by Soares et al. (2003).
This analysis allowed defining various subgroups of sequences within
group A, where the Argentinean strains formed a separate subgroup
associated with the NADL-2 strain and Brazilian strains related to
reproductive clinical presentation. Whether this similarity is associated
with the detection of PPV in mummies and stillbirths or depends on other
factors should be further analyzed. Few differences regarding the groups
were detected when including the Argentinean and new Brazilian strains.
Four Brazilian strains were within group B, in disagreement with that
reported by Soares et al. (2003). In this study, all German strains included
formed the subgroup c, all represented by virulent strains. Germany has a
long PPV infection history and the genetic variability is complicated.
Zimmermann et al. (2006) described a phylogenetic analysis of the
full-length VP1 nucleotide sequences of German isolates and showed two
defined clusters. In the present study, when we analyzed the amino acid
sequence, we also analyzed the differences of residues at the positions
described between Kresse and NADL-2 strains. We found that all field
strains detected and analyzed have the same residues of NADL-2 at the
amino acid positions 436 and 565 in the VP2 fragment. Similar results
were obtained by Soares et al. (2003), who found that position 436 is one
of the responsible ones for differences in tropism (allotropic determinant)
between virulent PPV isolates and the NADL-2 strain. Like Soares, we can
conclude that amino acid 436 is the one responsible for tissue tropism,
and, based on the results of the present study, we can also conclude that it
seems to be the main residue involved in the differentiation of the
clusters.
This study showed the presence of PPV DNA in fetal tissues (mummies
and stillbirths) of sows without reproductive failure, a fact that suggests a
subclinical effect of PPV infection. Moreover, the 10 isolates reported
here represent the first report of PPV in Argentina and are related to the
strains isolated in Brazil.
This study provides information that needs to be studied in depth so
as to improve prevention and control strategies for PPV infection in swine
farms.
5. Conclusions
The results provides information about the PPV strains isolated from a
2500-sow multi-site farrow-to-finish farm located in Santa Fe province,5
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